May 4, 2022

Welcome@machineMD: Phil Norris - Head of Commercial Strategy with a long-standing interest in digital health and applications of virtual reality

Phil Norris has just joined machineMD as Head of Commercial Strategy. He looks towards the launch of the NeurOphthalmoscope by planning how machineMD can best provide value to Neurologists and Ophthalmologists through building a customer-centric commercial team. Through this very early involvement, it is possible to position the doctor and the patient at the centre of the organisation from the very beginning. 

Phil has long been interested in the potential applications of virtual reality in digital health and is an advisor to Virtual Switzerland. Developing a clinical application with one of the most advanced VR headsets is very exciting for him, and he is very impressed that machineMD is already diving deep into artificial intelligence based on real clinical data.

The next milestones for him are the product launches in various markets. Along the way he is looking forward to building relationships with medical experts, medical societies, and collaborating with other industry specialists.  

Phil Norris brings a decade of working with pharma, biotech, and medtech companies, particularly at the intersection of digital health and artificial intelligence. Most recently he worked with an award-winning medical education company, VirtaMed, while completing an Executive MBA at the International Institute for Management Development (IMD). 

Get in touch

Contact us

For all enquiries, please contact us using the form below. We are looking forward to hearing from you.

Join our mailing list

Newsletter

Sign up to receive updates from machineMD delivered to your inbox.

Subscribe
You have successfully subscribed to our newsletter. Thank you.
Something went wrong while submitting the form.
Please try again or contact us directly at info@machinemd.com

Ihr Browser ist veraltet

Wir haben bemerkt, dass Sie derzeit eine alte Version des Internet Explorer verwenden. Wir empfehlen Ihnen, einen der folgenden Browser zu verwenden: